ArticleJournal of diabetes and metabolic disorders2020

The comparison of efficacy and safety between different doses of empagliflozin in insulin-treated type 1 diabetes mellitus patients: a systematic review and meta-analysis protocol.

Sumanta Saha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.